About Alpha-9 Oncology
Alpha-9 Oncology is a clinical-stage biotechnology company developing radiopharmaceuticals for solid and hematologic malignancies.
Open positions (1)
Company details
Funding
Total raised
$261
Last stage
Growth
Investors
Founders
David Perrin
Leading researcher in radiopharmaceuticals and drug design. Co-founder of Alpha-9 Oncology.
Kuo-Shyan Lin
Leading researcher in radiopharmaceuticals and drug design. Co-founder of Alpha-9 Oncology.
François Bénard
Leading researcher in radiopharmaceuticals. Co-founder of Alpha-9 Oncology, spun out from University of British Columbia and BC Cancer.
What happens next.
No applications, no recruiter spam. Just the intro.
Confirm the fit
A few questions to make sure this role is the right shape for you. Two minutes.
I pitch you to the company
I write the intro, send it to the founder, and handle the back-and-forth.
A meeting lands on your calendar
If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.